(UGI) UGI - Overview
Stock: Energy Distribution, Propane, Natural Gas, Electricity
| Risk 5d forecast | |
|---|---|
| Volatility | 18.6% |
| Relative Tail Risk | -7.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | 10.43 |
| Character TTM | |
|---|---|
| Beta | 0.278 |
| Beta Downside | 0.488 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.23% |
| CAGR/Max DD | 0.15 |
EPS (Earnings per Share)
Revenue
Description: UGI UGI March 04, 2026
UGI Corporation is an energy company operating in the United States and internationally. It distributes, stores, transports, and markets various energy products and services. The companys business model spans multiple segments, including Utilities, Midstream & Marketing, UGI International, and AmeriGas Propane.
The Utilities segment involves natural gas and electricity distribution. Natural gas utilities, a regulated industry, typically operate with defined service territories. UGI distributes natural gas to customers in Pennsylvania and electricity to customers in northeastern Pennsylvania.
Through its Midstream & Marketing segment, UGI manages natural gas pipelines, storage, and related infrastructure. Midstream operations are critical for connecting energy production to consumption centers.
UGI International and AmeriGas Propane focus on the distribution of propane and liquefied petroleum gases (LPG). Propane is a versatile fuel used across residential, commercial, industrial, and agricultural sectors.
For more detailed financial analysis, consider exploring ValueRays comprehensive reports on UGI. Additionally, the company operates electric generation facilities and various storage and transshipment terminals, supporting its diverse energy offerings.
Headlines to watch out for
- Propane and LPG sales drive significant revenue
- Natural gas distribution provides stable income
- Commodity price volatility impacts profitability
- Regulatory environment influences utility segment
- Weather patterns affect energy demand and sales
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 600.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.66 > 1.0 |
| NWC/Revenue: -7.90% < 20% (prev 0.11%; Δ -8.01% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.13b > Net Income 600.0m |
| Net Debt (6.52b) to EBITDA (1.61b): 4.04 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (221.4m) vs 12m ago 2.65% < -2% |
| Gross Margin: 49.01% > 18% (prev 0.54%; Δ 4.85k% > 0.5%) |
| Asset Turnover: 47.01% > 50% (prev 46.19%; Δ 0.82% > 0%) |
| Interest Coverage Ratio: 2.50 > 6 (EBITDA TTM 1.61b / Interest Expense TTM 420.0m) |
Altman Z'' 1.44
| A: -0.04 (Total Current Assets 2.10b - Total Current Liabilities 2.68b) / Total Assets 15.81b |
| B: 0.22 (Retained Earnings 3.55b / Total Assets 15.81b) |
| C: 0.07 (EBIT TTM 1.05b / Avg Total Assets 15.61b) |
| D: 0.47 (Book Value of Equity 5.11b / Total Liabilities 10.80b) |
| Altman-Z'' Score: 1.44 = BB |
Beneish M -3.06
| DSRI: 0.87 (Receivables 1.05b/1.17b, Revenue 7.34b/7.12b) |
| GMI: 1.11 (GM 49.01% / 54.35%) |
| AQI: 0.97 (AQ_t 0.29 / AQ_t-1 0.30) |
| SGI: 1.03 (Revenue 7.34b / 7.12b) |
| TATA: -0.03 (NI 600.0m - CFO 1.13b) / TA 15.81b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of UGI shares?
Over the past week, the price has changed by -0.11%, over one month by -4.92%, over three months by -3.78% and over the past year by +14.56%.
Is UGI a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the UGI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.5 | 22.5% |
| Analysts Target Price | 44.5 | 22.5% |
UGI Fundamental Data Overview March 15, 2026
P/E Forward = 7.728
P/S = 1.0866
P/B = 1.5807
P/EG = 48.818
Revenue TTM = 7.34b USD
EBIT TTM = 1.05b USD
EBITDA TTM = 1.61b USD
Long Term Debt = 5.97b USD (from longTermDebt, last quarter)
Short Term Debt = 807.0m USD (from shortTermDebt, last quarter)
Debt = 6.77b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.52b USD (from netDebt column, last quarter)
Enterprise Value = 14.50b USD (7.98b + Debt 6.77b - CCE 251.0m)
Interest Coverage Ratio = 2.50 (Ebit TTM 1.05b / Interest Expense TTM 420.0m)
EV/FCF = 51.41x (Enterprise Value 14.50b / FCF TTM 282.0m)
FCF Yield = 1.95% (FCF TTM 282.0m / Enterprise Value 14.50b)
FCF Margin = 3.84% (FCF TTM 282.0m / Revenue TTM 7.34b)
Net Margin = 8.17% (Net Income TTM 600.0m / Revenue TTM 7.34b)
Gross Margin = 49.01% ((Revenue TTM 7.34b - Cost of Revenue TTM 3.74b) / Revenue TTM)
Gross Margin QoQ = 51.42% (prev 50.46%)
Tobins Q-Ratio = 0.92 (Enterprise Value 14.50b / Total Assets 15.81b)
Interest Expense / Debt = 1.64% (Interest Expense 111.0m / Debt 6.77b)
Taxrate = 15.38% (54.0m / 351.0m)
NOPAT = 888.5m (EBIT 1.05b * (1 - 15.38%))
Current Ratio = 0.78 (Total Current Assets 2.10b / Total Current Liabilities 2.68b)
Debt / Equity = 1.35 (Debt 6.77b / totalStockholderEquity, last quarter 5.00b)
Debt / EBITDA = 4.04 (Net Debt 6.52b / EBITDA 1.61b)
Debt / FCF = 23.13 (Net Debt 6.52b / FCF TTM 282.0m)
Total Stockholder Equity = 4.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.84% (Net Income 600.0m / Total Assets 15.81b)
RoE = 12.21% (Net Income TTM 600.0m / Total Stockholder Equity 4.92b)
RoCE = 9.65% (EBIT 1.05b / Capital Employed (Equity 4.92b + L.T.Debt 5.97b))
RoIC = 7.40% (NOPAT 888.5m / Invested Capital 12.00b)
WACC = 4.39% (E(7.98b)/V(14.75b) * Re(6.94%) + D(6.77b)/V(14.75b) * Rd(1.64%) * (1-Tc(0.15)))
Discount Rate = 6.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.35%
[DCF] Terminal Value 83.14% ; FCFF base≈319.6m ; Y1≈244.0m ; Y5≈150.6m
[DCF] Fair Price = N/A (negative equity: EV 4.67b - Net Debt 6.52b = -1.86b; debt exceeds intrinsic value)
EPS Correlation: -2.84 | EPS CAGR: -10.50% | SUE: -0.11 | # QB: 0
Revenue Correlation: -48.05 | Revenue CAGR: -12.70% | SUE: -1.45 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.04 | Chg7d=-0.020 | Chg30d=-0.020 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-09-30): EPS=3.10 | Chg7d=-0.035 | Chg30d=-0.035 | Revisions Net=-1 | Growth EPS=-6.8% | Growth Revenue=+7.8%
EPS next Year (2027-09-30): EPS=3.40 | Chg7d=+0.025 | Chg30d=+0.025 | Revisions Net=-1 | Growth EPS=+9.7% | Growth Revenue=+2.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 7.9% - Earnings Yield 7.2%)
[Growth] Growth Spread = +15.4% (Analyst 16.1% - Implied 0.7%)